Evidence map›Paper›PMID 41445539›Full record

ReviewFrontiers in neuroanatomy2025

Functional neuroanatomy of dopaminergic arousal systems: implications for the wake-promoting effect of psychostimulants, with particular reference to modafinil.

Elemer Szabadi

Abstract readReview
In one paragraph

Review in Frontiers in neuroanatomy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Adenosine ABiomolecules & therapeutics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Elemer SzabadiDepartment of Psychiatry, University of Nottingham, Nottingham, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arousal involves activation of the cerebral cortex by inputs from subcortical (hypothalamic, brainstem) wake-promoting nuclei, utilizing monoamine (noradrenaline, dopamine, serotonin, histamine) and neuropeptide (orexin) neurotransmitters. Dopaminergic neurones of the midbrain, originating from distinct nuclei [pars compacta of substantia nigra (SNc), ventral tegmental area (VTA), and other clusters of dopaminergic neurones in the ventral periaqueductal gray (vPAG)] and the pontine dorsal raphe nucleus (DRN), constitute a powerful wake-promoting system. Cortical activation by dopaminergic neurones can be due to either direct projections from the VTA and vPAG/DRN, to the cerebral cortex, or indirect projections from the VTA via the nucleus accumbens (NAc)/ventral pallidum (VP) and from the SNc via the thalamus. Stimulation of the VP, by inputs from the VTA via the NAc, can activate wake-promoting noradrenergic and orexinergic neurones, and stimulation of the thalamus, by inputs from the SNc, can activate wake-promoting glutamatergic thalamocortical neurones. There is also a two-way mutually reinforcing connection between the VTA/NAc/VP and SNc/thalamus systems, indicating the key role of the NAc in dopaminergic arousal regulation. Dopaminergic psychostimulants (e.g., amphetamine, cocaine) are highly addictive drugs of abuse, that activate both reinforcement mechanisms and promote wakefulness, by enhancing dopaminergic neurotransmission. The addictive potential of psychostimulants is related to the stimulation of reinforcement processes. Modafinil, an atypical psychostimulant, enhances wakefulness without affecting reinforcement, and thus is devoid of addictive potential. Unraveling the mode of action of modafinil may give insight into the neural mechanisms controlling reinforcement and arousal. Recent evidence indicates that the powerful arousal-enhancing effect of psychostimulants may mainly be due to indirect cortical activation via the NAc and thalamus.

Indexed as

arousaldopaminergic nucleinucleus accumbenspsychostimulantssubstantia nigrathalamusventral pallidumVTA

Identifiers

PMID41445539
PMCPMC12722882

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.